Ikarian Capital, LLC Ocular Therapeutix, Inc Transaction History

Ikarian Capital, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $246,207 - $395,186	-78,410 Reduced 78.41%	21,590 $67,000
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $459,999 - $764,000	-100,000 Reduced 50.0%	100,000 $516,000
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $169,650 - $286,650	-65,000 Reduced 24.53%	200,000 $562,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $1.08 Million - $1.72 Million	265,000 New	265,000 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $89,228 - $154,741	-29,644 Closed	0 $0

Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $10,109 - $15,383	2,093 Added 7.6%	29,644 $147,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $1.54 Million - $3.02 Million	-250,000 Reduced 90.07%	27,551 $191,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $1.38 Million - $2.04 Million	-142,022 Reduced 33.85%	277,551 $2.78 Million
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $4.19 Million - $5.86 Million	-265,000 Reduced 38.71%	419,573 $6.89 Million
Q4 2020 Feb 12, 2021	SELL	$7.91 - $22.95 $8.16 Million - $23.7 Million	-1,031,720 Reduced 60.11%	684,573 $14.2 Million
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $2.5 Million - $3.35 Million	-339,684 Reduced 16.52%	1,716,293 $13.1 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $2.32 Million - $4.45 Million	497,041 Added 31.88%	2,055,977 $17.1 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $3.96 Million - $7.41 Million	1,001,277 Added 179.55%	1,558,936 $7.72 Million
Q4 2019 Jan 31, 2020	BUY	$2.57 - $4.73 $1.43 Million - $2.64 Million	557,659 New	557,659 $2.2 Million

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.